Marshall Wace
ELGX

Marshall Wace’s Endologix Inc ELGX Stock Holding History

Marshall Wace’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,838
Closed -$85K – 2253
2018
Q4 		$85K Sell
11,838
-635
-5% -$7.07K ﹤0.01% 1393
2018
Q3 		$238K Buy
+12,473
New +$445K ﹤0.01% 1041
2017
Q1 		– Sell
-32,730
Closed -$1.87M – 910
2016
Q4 		$1.87M Buy
32,730
+26,172
+399% +$2.4M 0.01% 650
2016
Q3 		$839K Buy
+6,558
New +$839K 0.01% 742
2016
Q2 		– Sell
-28,380
Closed -$2.37M – 1259
2016
Q1 		$2.37M Buy
28,380
+25,363
+841% +$2.09M 0.02% 525
2015
Q4 		$299K Buy
+3,017
New +$323K ﹤0.01% 876
2015
Q1 		– Sell
-1,117
Closed -$171K – 1000
2014
Q4 		$171K Buy
+1,117
New +$139K ﹤0.01% 756

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace's ELGX Position: Q1 2019 in Review

Marshall Wace sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 11,838 shares — an estimated $85K sold.

Marshall Wace first reported a position in ELGX in Q4 2014 and held it in 7 quarters. The position peaked at $2.37M in Q1 2016. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Marshall Wace reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Marshall Wace sold 11,838 Endologix Inc shares in Q1 2019, an estimated $85K.
  • Marshall Wace first reported a position in Endologix Inc in Q4 2014 and held it in 7 quarters.
  • Marshall Wace's Endologix Inc position peaked at $2.37M in Q1 2016.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.